Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count

被引:46
作者
La Marca, Antonio [1 ]
Grisendi, Valentina [1 ]
Giulini, Simone [1 ]
Argento, Cindy [1 ]
Tirelli, Alessandra [1 ]
Dondi, Giulia [1 ]
Papaleo, Enrico [2 ]
Volpe, Annibale [1 ]
机构
[1] Univ Modena & Reggio Emilia, Inst Obstet & Gynecol, Mother Infant Dept, I-41100 Modena, Italy
[2] Hosp San Raffaele, Dept Obstet Gynecol, Ctr Natalita, I-20132 Milan, Italy
来源
JOURNAL OF OVARIAN RESEARCH | 2013年 / 6卷
关键词
Starting FSH dose; ART; AFC; FSH; Ovarian reserve; ANTI-MULLERIAN HORMONE; CONTROLLED OVARIAN STIMULATION; IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; RANDOMIZED CLINICAL-TRIAL; PREDICTIVE FACTORS; RECOMBINANT FSH; STANDARD PATIENTS; 150; IU/DAY; IVF;
D O I
10.1186/1757-2215-6-11
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The FSH starting dose is usually chosen according to women's age, anamnesis, clinical criteria and markers of ovarian reserve. Currently used markers include antral follicle count (AFC), which is considered to have a very high performance in predicting ovarian response to FSH. The objective of the present study to elaborate a nomogram based on AFC for the calculation of the appropriate FSH starting dose in IVF cycles. Methods: This is a retrospective study performed at the Mother-Infant Department of Modena University Hospital. IVF patients (n=505) were subjected to blood sampling and transvaginal ultrasound for measurement of serum day3 FSH, estradiol and AFC. The variables predictive of the number of retrieved oocytes were assessed by backwards stepwise multiple regression. The variables reaching the statistical significance were then used in the calculation for the final predictive model. Results: A model based on age, AFC and FSH was able to accurately predict the ovarian sensitivity and accounted for 30% of the variability of ovarian response to FSH. An FSH dosage nomogram was constructed and overall it predicts a starting dose lower than 225 IU in 50.2% and 18.1% of patients younger and older than 35 years, respectively. Conclusions: The daily FSH dose may be calculated on the basis of age and two markers of ovarian reserve, namely AFC and FSH, with the last two variables being the most significant predictors. The nomogram seems easily applicable during the daily clinical practice.
引用
收藏
页数:8
相关论文
共 27 条
  • [11] A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-β) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles
    Harrison, RF
    Jacob, S
    Spillane, H
    Mallon, E
    Hennelly, B
    [J]. FERTILITY AND STERILITY, 2001, 75 (01) : 23 - 31
  • [12] Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count
    Hendriks, Dave J.
    Kwee, Janet
    Mol, Ben W. J.
    te Velde, Egbert R.
    Broekmans, Frank J. M.
    [J]. FERTILITY AND STERILITY, 2007, 87 (04) : 764 - 775
  • [13] Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients
    Howles, C. M.
    Saunders, H.
    Alam, V.
    Engrand, P.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (05) : 907 - 918
  • [14] A population model for the follicular growth in women treated with follicle stimulating hormone
    Karlsson, MO
    Wade, JR
    Loumaye, E
    Munafo, A
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (06) : 665 - 674
  • [15] Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology
    La Marca, A.
    Giulini, S.
    Tirelli, A.
    Bertucci, E.
    Marsella, T.
    Xella, S.
    Volpe, A.
    [J]. HUMAN REPRODUCTION, 2007, 22 (03) : 766 - 771
  • [16] Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles
    La Marca, A.
    Papaleo, E.
    Grisendi, V.
    Argento, C.
    Giulini, S.
    Volpe, A.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (10) : 1171 - 1179
  • [17] Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
    La Marca, A.
    Sighinolfi, G.
    Radi, D.
    Argento, C.
    Baraldi, E.
    Artenisio, A. Carducci
    Stabile, G.
    Volpe, A.
    [J]. HUMAN REPRODUCTION UPDATE, 2010, 16 (02) : 113 - 130
  • [18] Possibilities and Limits of Ovarian Reserve Testing in ART
    La Marca, Antonio
    Argento, Cindy
    Sighinolfi, Giovanna
    Grisendi, Valentina
    Carbone, Marilena
    D'Ippolito, Giovanni
    Artenisio, Alfredo Carducci
    Stabile, Gaspare
    Volpe, Annibale
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (03) : 398 - 408
  • [19] Age-specific nomogram for the decline in antral follicle count throughout the reproductive period
    La Marca, Antonio
    Spada, Elena
    Sighinolfi, Giovanna
    Argento, Cindy
    Tirelli, Alessandra
    Giulini, Simone
    Milani, Silvano
    Volpe, Annibale
    [J]. FERTILITY AND STERILITY, 2011, 95 (02) : 684 - 688
  • [20] Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles - implications for individualization of therapy
    Nelson, Scott M.
    Yates, Robin W.
    Fleming, Richard
    [J]. HUMAN REPRODUCTION, 2007, 22 (09) : 2414 - 2421